Recombinant B subunit-bacterial O139 cholera vaccine (Shanghai united cell biotechnology)
重组B亚单位-菌体O139霍乱疫苗（上海联合赛尔生物）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant B subunit-bacterial O139 cholera vaccine (Shanghai united cell biotechnology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesLanzhou Institute Of Biological Products Co LtdInstitute Of Bioengineering, Academy Of Military Medical SciencesShanghai United Cell Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesInstitute of Bioengineering Academy of Military Medical Sciences Chinese People's Liberation ArmyShanghai United Cell Biotechnology Co LtdLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A